We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

65 hedge funds and large institutions have $817M invested in Akcea Therapeutics Inc in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

51% more capital invested

Capital invested by funds: $541M → $817M (+$277M)

16% more funds holding

Funds holding: 56 → 65 (+9)

5% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 19

68% less call options, than puts

Call options by funds: $13.4M | Put options by funds: $41.6M

Holders
65
Holders Change
+9
Holders Change %
+16.07%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
18
Reduced
19
Closed
9
Calls
$13.4M
Puts
$41.6M
Net Calls
-$28.1M
Net Calls Change
-$28.9M

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$22.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.2M
3
SC
Sculptor Capital
New York
+$3.24M
4
State Street
State Street
Massachusetts
+$2.9M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.41M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$25.1M
2
AGA
Altrinsic Global Advisors
Connecticut
-$3.1M
3
BB
BB Biotech
Switzerland
-$2.95M
4
Millennium Management
Millennium Management
New York
-$1.52M
5
Goldman Sachs
Goldman Sachs
New York
-$523K
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
$79K +$10.2K +338 +18%
Canada Life
52
Canada Life
Manitoba, Canada
$72K – – –
OTC
53
Opera Trading Capital
France
$64K +$55K +1,818 New
AIP
54
Ameritas Investment Partners
Nebraska
$45K – – –
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
$25.9K +$1.7K +56 +8%
CG
56
Cutler Group
California
$14K – – –
Daiwa Securities Group
57
Daiwa Securities Group
Japan
$13K – – –
BA
58
Ballew Advisors
Mississippi
$6K +$7.41K +245 New
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
$4K +$1.39K +46 +72%
Bank of Montreal
60
Bank of Montreal
Ontario, Canada
$3K -$61 -2 -2%
QI
61
QS Investors
New York
$2K – – –
SIM
62
Sonora Investment Management
Arizona
$2K – – –
MAM
63
Meeder Asset Management
Ohio
$2K +$2K +66 New
HMS
64
Hanseatic Management Services
New Mexico
$1K +$1.06K +35 New
WSTAM
65
Wilbanks Smith & Thomas Asset Management
Virginia
$1K +$1.21K +40 New
Millennium Management
66
Millennium Management
New York
– -$1.52M -63,998 Closed
BFM
67
Boothbay Fund Management
New York
– -$270K -11,400 Closed
PP
68
Paloma Partners
Connecticut
– -$216K -9,100 Closed
VF
69
Virtu Financial
New York
– -$207K -8,722 Closed
TRCT
70
Tower Research Capital (TRC)
New York
– -$82K -3,477 Closed
PIA
71
Piedmont Investment Advisors
North Carolina
– -$5K -221 Closed
Fifth Third Bancorp
72
Fifth Third Bancorp
Ohio
– -$4K -150 Closed
AG
73
Advisor Group
Arizona
– -$2K -100 Closed
1 2
3

AKCA Hedge Fund Activity: Q3 2018 in Review

65 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q3 2018, worth a combined $817M — up 51% from $541M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AKCA positions and 9 closed out — a net gain of 9 holders — while 18 added to existing stakes and 19 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $22.8M. The largest seller was Wellington Management Group, cutting an estimated $25.1M.

  • 65 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q3 2018, up from 56 in Q2 2018.
  • Funds reported $817M of Akcea Therapeutics Inc stock for Q3 2018, up 51% quarter-over-quarter.
  • 18 funds opened new Akcea Therapeutics Inc positions in Q3 2018 and 9 closed out, a net change of +9 holders.
  • The largest Akcea Therapeutics Inc buyer in Q3 2018 was EcoR1 Capital, an estimated $22.8M added.
  • The largest Akcea Therapeutics Inc seller in Q3 2018 was Wellington Management Group, an estimated $25.1M sold.

Based on aggregated 13F filings for Q3 2018.